Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Axonics, Inc. (Nasdaq: AXNX), a ...

BSX's acquisition of Axonics marks its entry into sacral neuromodulation and complements its Urology business.

Boston Scientific announced the acquisition in January, but the review dragged on after the Federal Trade Commission ...

Boston Scientific (NYSE: BSX) today announced the completion of its $3.7 billion acquisition of Axonics, Inc. (Nasdaq: AXNX).

Boston Scientific Corp. last week announced that it has closed on its acquisition of Irvine-based medical device maker ...

Boston Scientific Corporation's acquisition of Axonics, Inc. for $3.7 billion expands urology offerings with innovative ...

On Thursday, Axonics Inc (AXNX) stock saw a modest uptick, ending the day at $70.98 which represents a slight increase of $0.53 or 0.75% from the prior close of $70.45. The stock opened at $70.5 and ...

MARLBOROUGH, Mass. - Boston Scientific Corporation (NYSE:BSX) has finalized its acquisition of Axonics, Inc. (NASDAQ:AXNX), a company specializing in medical devices for urinary and bowel ...

The latest update is out from Axonics Modulation Technologies ( (AXNX) ). The merger completed on November 15, 2024, transformed the Company ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

IRVINE, Calif. (AP) — IRVINE, Calif. (AP) — Axonics Modulation Technologies Inc. (AXNX) on Thursday reported a third-quarter loss of $21,000, after reporting a profit in the same period a year earlier ...

Boston Scientific (BSX) announced the close of its acquisition of Axonics (AXNX). The purchase price of $71 cash per share represents an ...